Noticias
Article by César A. Ramírez-Sarmiento, partner of SBBMCH, was awarded as the article of the year in the journal Biophysical Journal
BJ Paper of the Year Award César A. Ramírez-Sarmiento is the recipient of the Biophysical Journal Paper of the Year Award for his article, “Differential Local Stability Governs the Metamorphic Fold Switch
They find 4 genes that influence the course of Coronavirus
It's one of the pandemic puzzles: most people infected with SARS-CoV-2 never feel sick, while others develop severe symptoms or even end up
Structural on-site analysis of SARS-CoV-2 protein S reveals the existence of "hinges" that allow flexibility
SarS-CoV-2 spike (S) protein allows the virus to enter the host cell by binding to the angiotencin II (ACE2) converting enzyme receptor and is a large target
UC Medical Team manages to isolate the covid-19-causing virus in the lab
Recently an academic team, led by Dr. Marcela Ferrés, achieved an important step in researching the pandemic by covid-19: isolating SARS-CoV-2, the virus responsible for
Drifting researchers
If a public distribution cut the salaries off nearly a thousand of its workers, the news would be on the front page. What happens, then, in the case of those who are
New biofortification method that transforms leaves into nutrient deposits
A new collaborative study led by researchers from the Higher Council for Scientific Research (CSIC) at the Agricultural Genomics Research Center (CRAG) in Barcelona and the Institute of Biology
Sensitive death of Dr Maria Imschenetzky Popov
Dear Partners: We sadly inform you of the sensitive passing of Dr Maria Imschenetzky Popov yesterday. Dr. Imschenetzky, who in 2013 was appointed professor emeritus
Don’t Forget – Join Us For Webinar #3
Have you registered yet for our third Webinar? If not, there is still time! Webinar #3, entitled: Mechanisms of Molecular Chaperones: Insights from Hybrid Biophysical Approaches, will have two parts and take place
Antibody design could fight COVID-19 before vaccines arrive
While the world is paralyzed by the high-risk race to develop a COVID-19 vaccine, equally crucial competition is heating up to produce targeted antibodies that could provide
